AKSO HEALTH GR. (SPADR)/3 (8HX) - Total Assets
Based on the latest financial reports, AKSO HEALTH GR. (SPADR)/3 (8HX) holds total assets worth €212.04 Million EUR (≈ $247.90 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See AKSO HEALTH GR. (SPADR)/3 book value and equity for net asset value and shareholders' equity analysis.
AKSO HEALTH GR. (SPADR)/3 - Total Assets Trend (2022–2025)
This chart illustrates how AKSO HEALTH GR. (SPADR)/3's total assets have evolved over time, based on quarterly financial data.
AKSO HEALTH GR. (SPADR)/3 - Asset Composition Analysis
Current Asset Composition (March 2025)
AKSO HEALTH GR. (SPADR)/3's total assets of €212.04 Million consist of 91.2% current assets and 8.8% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 82.0% |
| Accounts Receivable | €954.20K | 0.4% |
| Inventory | €190.24K | 0.1% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €7.88 Million | 3.7% |
| Goodwill | €10.83 Million | 5.0% |
Asset Composition Trend (2022–2025)
This chart illustrates how AKSO HEALTH GR. (SPADR)/3's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 8HX market cap overview.
Key Asset Composition Facts
- Current vs. Non-Current Assets: AKSO HEALTH GR. (SPADR)/3's current assets represent 91.2% of total assets in 2025, a decrease from 99.7% in 2022.
- Cash Position: Cash and equivalents constituted 82.0% of total assets in 2025, up from 29.3% in 2022.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 8.0% of total assets, an increase from 0.0% in 2022.
- Asset Diversification: The largest asset category is goodwill at 5.0% of total assets.
AKSO HEALTH GR. (SPADR)/3 Competitors by Total Assets
Key competitors of AKSO HEALTH GR. (SPADR)/3 based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Jointown Pharmaceutical Group Co Ltd
SHG:600998
|
China | CN¥112.28 Billion |
|
Guangxi Liuzhou Pharm Co Ltd
SHG:603368
|
China | CN¥21.18 Billion |
|
Cyclopharm Ltd
AU:CYC
|
Australia | AU$46.10 Million |
|
Sigma Healthcare Ltd
AU:SIG
|
Australia | AU$8.74 Billion |
|
Ebos Group Ltd
AU:EBO
|
Australia | AU$8.80 Billion |
|
Paragon Care Ltd
AU:PGC
|
Australia | AU$1.31 Billion |
|
Mayne Pharma Group Ltd
AU:MYX
|
Australia | AU$1.01 Billion |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
|
Brazil | R$5.64 Billion |
AKSO HEALTH GR. (SPADR)/3 - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.53 | 8.19 | 8.19 |
| Quick Ratio | 1.51 | 8.18 | 8.18 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €6.37 Million | €87.98 Million | €87.98 Million |
AKSO HEALTH GR. (SPADR)/3 - Advanced Valuation Insights
This section examines the relationship between AKSO HEALTH GR. (SPADR)/3's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 8.46 |
| Latest Market Cap to Assets Ratio | 7.45 |
| Asset Growth Rate (YoY) | 51.4% |
| Total Assets | €214.95 Million |
| Market Capitalization | $1.60 Billion USD |
Valuation Analysis
Premium Asset Valuation: The market values AKSO HEALTH GR. (SPADR)/3's assets at a significant premium (7.45x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: AKSO HEALTH GR. (SPADR)/3's assets grew by 51.4% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for AKSO HEALTH GR. (SPADR)/3 (2022–2025)
The table below shows the annual total assets of AKSO HEALTH GR. (SPADR)/3 from 2022 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | €214.95 Million ≈ $251.30 Million |
+51.36% |
| 2024-03-31 | €142.02 Million ≈ $166.03 Million |
+594.12% |
| 2023-03-31 | €20.46 Million ≈ $23.92 Million |
-67.42% |
| 2022-03-31 | €62.81 Million ≈ $73.43 Million |
-- |
About AKSO HEALTH GR. (SPADR)/3
Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People's Republic of China. It operates Xiaobai Maimai App, a social e-commerce mobile platform that offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. The compan… Read more